CFS/ME Working Group. A report of the CFS/ME working group: report to the chief medical officer of an independent working group. London: Department of Health, 2002. Fulltext at DOH.
doi.org
Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A (15 December 1994). "The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group". Ann Intern Med (英語). 121 (12): 953–9. doi:10.1059/0003-4819-121-12-199412150-0000 (inactive 11 January 2015). PMID7978722。
Reuter SE, Evans AM (2011 Jul). “Long-chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase-I activity”. J Intern Med.270 (1): 76-84. doi:10.1111/j.1365-2796.2010.02341.x. PMID21205027.
Nakatomi Y, Mizuno K, Ishii A, Wada Y, Tanaka M, Tazawa S, Onoe K, Fukuda S, Kawabe J, Takahashi K, Kataoka Y, Shiomi S, Yamaguti K, Inaba M, Kuratsune H, Watanabe Y (2014 Jun). “Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An ¹¹C-(R)-PK11195 PET Study”. J Nucl Med.55: 945-50. doi:10.2967/jnumed.113.131045. PMID24665088.
VabElzakker MB, Brumfield SA, Lara Mejia PS (2019 Jan 10). “Neuroinflammation and Cytokines in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Critical Review of Research Methods.”. Front Neurol9: 1033. doi:10.3389/fneur.2018.01033. PMID30687207.
VabElzakker MB, Brumfield SA, Lara Mejia PS (2019 Apr 2). “Corrigendum: Neuroinflammation and Cytokines in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Critical Review of Research Methods.”. Front Neurol10: 316. doi:10.3389/fneur.2019.00316. PMID31001197.
Jason LA, Taylor RR (04 Dec 2011). “Measuring Attributions About Chronic Fatigue Syndrome”. J Chronic Fatigue Syndr8 (3-4): 31-40. doi:10.1300/J092v08n03_04.
Natelson BH, Haghighi MH, Ponzio NM (2002 Jul). “Evidence for the presence of immune dysfunction in chronic fatigue syndrome”. J Intern Med.9 (4): 747-52. doi:10.1128/cdli.9.4.747-752.2002. PMID12093668.
Sakudo A, Kuratsune H, Kobayashi T, Tajima S, Watanabe Y, Ikuta K (2006 Jul 14). “Spectroscopic diagnosis of chronic fatigue syndrome by visible and near-infrared spectroscopy in serum samples”. Biochem Biophys Res Commun.345 (4): 1513-6. doi:10.1016/j.bbrc.2006.05.074. PMID16730652.
Sakudo A, Kuratsune H, Kato YH, Ikuta K (2012 Oct 9). “Visible and near-infrared spectra collected from the thumbs of patients with chronic fatigue syndrome for diagnosis”. Clin Chim Acta413 (19-20): 1629-32. doi:10.1016/j.cca.2012.05.004. PMID22583968.
Yamano E, Sugimoto M, Hirayama A, Kume S, Yamato M, Jin G, Tajima S, Goda N, Iwai K, Fukuda S, Yamaguti K, Kuratsune H, Soga T, Watanabe Y, Kataoka Y (2016 Oct 11). “Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles”. Sci Rep.34990. doi:10.1038/srep34990. PMID27725700.
Eguchi A, Fukuda S, Kuratsune H, Nojima J, Nakatomi Y, Watanabe Y, Feldstein AE (2019 Nov 20). “Identification of actin network proteins, talin-1 and filamin-A, in circulating extracellular vesicles as blood biomarkers for human myalgic encephalomyelitis/chronic fatigue syndrome”. Brain Behav Immun.. doi:10.1016/j.bbi.2019.11.015. PMID31759091.
Almenar-Pérez E, Sarría L, Nathanson L, Oltra E (2020 Feb 7). “Assessing diagnostic value of microRNAs from peripheral blood mononuclear cells and extracellular vesicles in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome”. Sci Rep.10 (1). doi:10.1038/s41598-020-58506-5. PMID32034172.
Katz BZ, Shiraishi Y, Mears CJ, Binns HJ, Taylor R (2009). “Chronic fatigue syndrome after infectious mononucleosis in adolescents”. Pediatrics124 (1): 189-93. doi:10.1542/peds.2008-1879. PMID19564299.
Dietert RR, Dietert JM (2008 May 2). “Possible role for early-life immune insult including developmental immunotoxicity in chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME)”. Toxicology247 (1): 61-72. doi:10.1016/j.tox.2008.01.022. PMID18336982.
Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Silverman RH, Mikovits JA (2009). “Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome”. Science326 (5952): 585-9. doi:10.1126/science.1179052. PMID19815723.
Saiki, T., Kawai, T., Morita, K., Ohta, M., Saito, T., Rokutan, K., & Ban, N. (2008). “Identification of marker genes for differential diagnosis of chronic fatigue syndrome.”. Molecular Medicine14 (9-10): 599-607. doi:10.2119/2007-00059.Saiki. PMID18596870.
Hornig M, Montoya JG, Klimas NG, Levine S, Felsenstein D, Bateman L, Peterson DL, Gottschalk CG, Schultz AF, Che X, Eddy ML, Komaroff AL, Lipkin WI (2015 Feb). “Distinct plasma immune signatures in ME/CFS are present early in the course of illness”. Sci Adv.1 (1). doi:10.1126/sciadv.1400121. PMID26079000.
Phelan J, Grabowska AD, Sepúlveda N (2020 Feb 13). “A potential antigenic mimicry between viral and human proteins linking Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with autoimmunity: The case of HPV immunization.”. Autoimmun Rev.: 102487. doi:10.1016/j.autrev.2020.102487. PMID32062027.
Yasui M, Yoshimura T, Takeuchi S, Tokizane K, Tsuda M, Inoue K, Kiyama H (2004). “A chronic fatigue syndrome model demonstrates mechanical allodynia and muscular hyperalgesia via spinal microglial activation.”. Glia62 (9): 1407-17. doi:10.1002/glia.22687. PMID24852223.
Oka T, Tanahashi T, Chijiwa T, Lkhagvasuren B, Sudo N, Oka K (2014 Dec 11). “Isometric yoga improves the fatigue and pain of patients with chronic fatigue syndrome who are resistant to conventional therapy: a randomized, controlled trial”. Biopsychosoc Med.8 (1): 27. doi:10.1186/s13030-014-0027-8. PMID25525457.
Oka T, Wakita H, Kimura K (2017 Mar 3). “Development of a recumbent isometric yoga program for patients with severe chronic fatigue syndrome/myalgic encephalomyelitis: A pilot study to assess feasibility and efficacy”. Biopsychosoc Med.11: 5. doi:10.1186/s13030-017-0090-z. PMID28270860.
Cairns R, Hotopf M (2005 Jan). “A systematic review describing the prognosis of chronic fatigue syndrome”. Occup Med (Lond)55 (1): 20-31. doi:10.1093/occmed/kqi013. PMID15699087.
Vernon SD, Whistler T, Aslakson E, Rajeevan M, Reeves WC (2006). “Challenges for molecular profiling of chronic fatigue syndrome”. Pharmacogenomics7 (2): 211-8. doi:10.2217/14622416.7.2.211. PMID16515400.
Jason LA, Corradi K, Gress S, Williams S, Torres-Harding S (2006 Aug). “Causes of death among patients with chronic fatigue syndrome”. Health Care Women Int.27 (7): 615-26. doi:10.1080/07399330600803766. PMID16844674.
Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A (15 December 1994). "The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group". Ann Intern Med (英語). 121 (12): 953–9. doi:10.1059/0003-4819-121-12-199412150-0000 (inactive 11 January 2015). PMID7978722。
Reuter SE, Evans AM (2011 Jul). “Long-chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase-I activity”. J Intern Med.270 (1): 76-84. doi:10.1111/j.1365-2796.2010.02341.x. PMID21205027.
Nakatomi Y, Mizuno K, Ishii A, Wada Y, Tanaka M, Tazawa S, Onoe K, Fukuda S, Kawabe J, Takahashi K, Kataoka Y, Shiomi S, Yamaguti K, Inaba M, Kuratsune H, Watanabe Y (2014 Jun). “Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An ¹¹C-(R)-PK11195 PET Study”. J Nucl Med.55: 945-50. doi:10.2967/jnumed.113.131045. PMID24665088.
VabElzakker MB, Brumfield SA, Lara Mejia PS (2019 Jan 10). “Neuroinflammation and Cytokines in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Critical Review of Research Methods.”. Front Neurol9: 1033. doi:10.3389/fneur.2018.01033. PMID30687207.
VabElzakker MB, Brumfield SA, Lara Mejia PS (2019 Apr 2). “Corrigendum: Neuroinflammation and Cytokines in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Critical Review of Research Methods.”. Front Neurol10: 316. doi:10.3389/fneur.2019.00316. PMID31001197.
Natelson BH, Haghighi MH, Ponzio NM (2002 Jul). “Evidence for the presence of immune dysfunction in chronic fatigue syndrome”. J Intern Med.9 (4): 747-52. doi:10.1128/cdli.9.4.747-752.2002. PMID12093668.
Sakudo A, Kuratsune H, Kobayashi T, Tajima S, Watanabe Y, Ikuta K (2006 Jul 14). “Spectroscopic diagnosis of chronic fatigue syndrome by visible and near-infrared spectroscopy in serum samples”. Biochem Biophys Res Commun.345 (4): 1513-6. doi:10.1016/j.bbrc.2006.05.074. PMID16730652.
Sakudo A, Kuratsune H, Kato YH, Ikuta K (2012 Oct 9). “Visible and near-infrared spectra collected from the thumbs of patients with chronic fatigue syndrome for diagnosis”. Clin Chim Acta413 (19-20): 1629-32. doi:10.1016/j.cca.2012.05.004. PMID22583968.
Yamano E, Sugimoto M, Hirayama A, Kume S, Yamato M, Jin G, Tajima S, Goda N, Iwai K, Fukuda S, Yamaguti K, Kuratsune H, Soga T, Watanabe Y, Kataoka Y (2016 Oct 11). “Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles”. Sci Rep.34990. doi:10.1038/srep34990. PMID27725700.
Eguchi A, Fukuda S, Kuratsune H, Nojima J, Nakatomi Y, Watanabe Y, Feldstein AE (2019 Nov 20). “Identification of actin network proteins, talin-1 and filamin-A, in circulating extracellular vesicles as blood biomarkers for human myalgic encephalomyelitis/chronic fatigue syndrome”. Brain Behav Immun.. doi:10.1016/j.bbi.2019.11.015. PMID31759091.
Almenar-Pérez E, Sarría L, Nathanson L, Oltra E (2020 Feb 7). “Assessing diagnostic value of microRNAs from peripheral blood mononuclear cells and extracellular vesicles in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome”. Sci Rep.10 (1). doi:10.1038/s41598-020-58506-5. PMID32034172.
Katz BZ, Shiraishi Y, Mears CJ, Binns HJ, Taylor R (2009). “Chronic fatigue syndrome after infectious mononucleosis in adolescents”. Pediatrics124 (1): 189-93. doi:10.1542/peds.2008-1879. PMID19564299.
Dietert RR, Dietert JM (2008 May 2). “Possible role for early-life immune insult including developmental immunotoxicity in chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME)”. Toxicology247 (1): 61-72. doi:10.1016/j.tox.2008.01.022. PMID18336982.
Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Silverman RH, Mikovits JA (2009). “Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome”. Science326 (5952): 585-9. doi:10.1126/science.1179052. PMID19815723.
Saiki, T., Kawai, T., Morita, K., Ohta, M., Saito, T., Rokutan, K., & Ban, N. (2008). “Identification of marker genes for differential diagnosis of chronic fatigue syndrome.”. Molecular Medicine14 (9-10): 599-607. doi:10.2119/2007-00059.Saiki. PMID18596870.
Hornig M, Montoya JG, Klimas NG, Levine S, Felsenstein D, Bateman L, Peterson DL, Gottschalk CG, Schultz AF, Che X, Eddy ML, Komaroff AL, Lipkin WI (2015 Feb). “Distinct plasma immune signatures in ME/CFS are present early in the course of illness”. Sci Adv.1 (1). doi:10.1126/sciadv.1400121. PMID26079000.
Phelan J, Grabowska AD, Sepúlveda N (2020 Feb 13). “A potential antigenic mimicry between viral and human proteins linking Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with autoimmunity: The case of HPV immunization.”. Autoimmun Rev.: 102487. doi:10.1016/j.autrev.2020.102487. PMID32062027.
Yasui M, Yoshimura T, Takeuchi S, Tokizane K, Tsuda M, Inoue K, Kiyama H (2004). “A chronic fatigue syndrome model demonstrates mechanical allodynia and muscular hyperalgesia via spinal microglial activation.”. Glia62 (9): 1407-17. doi:10.1002/glia.22687. PMID24852223.
Oka T, Tanahashi T, Chijiwa T, Lkhagvasuren B, Sudo N, Oka K (2014 Dec 11). “Isometric yoga improves the fatigue and pain of patients with chronic fatigue syndrome who are resistant to conventional therapy: a randomized, controlled trial”. Biopsychosoc Med.8 (1): 27. doi:10.1186/s13030-014-0027-8. PMID25525457.
Oka T, Wakita H, Kimura K (2017 Mar 3). “Development of a recumbent isometric yoga program for patients with severe chronic fatigue syndrome/myalgic encephalomyelitis: A pilot study to assess feasibility and efficacy”. Biopsychosoc Med.11: 5. doi:10.1186/s13030-017-0090-z. PMID28270860.
Cairns R, Hotopf M (2005 Jan). “A systematic review describing the prognosis of chronic fatigue syndrome”. Occup Med (Lond)55 (1): 20-31. doi:10.1093/occmed/kqi013. PMID15699087.
Vernon SD, Whistler T, Aslakson E, Rajeevan M, Reeves WC (2006). “Challenges for molecular profiling of chronic fatigue syndrome”. Pharmacogenomics7 (2): 211-8. doi:10.2217/14622416.7.2.211. PMID16515400.
Jason LA, Corradi K, Gress S, Williams S, Torres-Harding S (2006 Aug). “Causes of death among patients with chronic fatigue syndrome”. Health Care Women Int.27 (7): 615-26. doi:10.1080/07399330600803766. PMID16844674.